Our ability to control infectious diseases is continuously being eroded by antimicrobial resistance, a current major health problem worldwide. A large proportion of the research activities in our group is related to the study of physiological and biochemical aspects of the mechanisms of resistance to antimicrobial agents in bacteria. We consider clinical relevant Enterobacteria and […]
Nowadays, osteoporosis due to the progressive aging of the population, is becoming one of the most frequent diseases of our time. Decreased quality of life (for example, inability to walk again after a hip fracture) and the increase in mortality it determines, justifies intensive research efforts. IDIVAL Bone and Lipid Metabolism Group, researchers at the […]
Researchers belonging to the Valdecilla Hospital and the University of Cantabria, of the IDIVAL Group Cytokines and growth factors in pathological tissue plasticity phenomena have collaborated in a study published last Monday in the prestigious journal Nature Medicine in which it is shown that the pharmacological inhibition of The NOS2 protein not only prevents pathological dilatation […]
T lymphocytes are blood cells whose mission is to destroy the malignant cells that affect our organism. They fight against diseased cells that sometimes originate in organs or those that have been infected by viruses. However, when they undergo certain genetic alterations they can cause tumors such as peripheral T-cell lymphomas, which have a very […]
The Board of IDIVAL at its meeting on December 16th approved the update of its composition with the incorporation of the following researchers: – Marcos López Hoyos. Coordinator of the Transplant Area of Organs and Tissues and New Therapies. Head of Immunology Service. University Hospital Marqués de Valdecilla. It replaces Dr. Manuel Arias, recently retired. […]
Frontiers in Immunology, the first most cited magazine in the field of Immunology and with high ranking, publishes in its open-access edition a coordinated work between the IDIVAL Research Institute (Group of Nanovacunas and cellular vaccines based on Listeria), Marqués de Valdecilla University Hospital (Microbiology Service and Section of Infectious Diseases) and the University Hospital […]
After analyzing more than 41,000 people (21,000 individuals with schizophrenia and 20,000 without it), the largest genomic study of schizophrenia to date has managed to isolate rare genetic variations that increase the risk of this disease. This study, recently published in Nature Genetics, has been conducted and led by the University of San Diego (USA), […]
The Massachusetts Institute of Technology (MIT) is the best Technical University in the world. Rafael Reif, president of the MIT, said in an interview for the Spanish newspaper El País on the 24th of October: “There are people from 152 countries in the MIT. Almost 80% of the nations are represented here. MIT has a […]
Dr. Riancho will be rewarded in the XIV National Research Awards due to his research on “Neuroprotective effect of bexarotene in the SOD1G93A mouse model of amyotrophic lateral sclerosis (ALS)” published in the magazine 'Frontiers in Cellular Neuroscience'. On the call has participated in total 16 research works, in which 10 are national projects and […]
The cognitive disorder unit of Valdecilla Hospital, under the direction of Pascual Sánchez-Juan, neurologist of Marques de Valdecilla University Hospital and researcher at IDIVAL, has developed a study to evaluate the effects of binge drinking associated with alterations of executive functions. In our analysis we observed that the students who binge drink obtained worse results […]
